|
GB1235529A
(en)
*
|
1968-12-02 |
1971-06-16 |
Calbiochem |
Composition for mucolysis
|
|
ES392136A1
(es)
|
1971-06-11 |
1973-03-01 |
Espanola Prod Quimicos |
Un procedimiento de obtencion de una sal de doxiciclina.
|
|
IT1134458B
(it)
|
1980-11-26 |
1986-08-13 |
Real Sas Di Alberto Reiner |
Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
|
|
IT1141959B
(it)
|
1981-01-27 |
1986-10-08 |
Istituto Biochimico Italiano |
Nuovi sali ad attivita' antibiotica e mucolitica
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
TWI236905B
(en)
*
|
1997-10-28 |
2005-08-01 |
Jens Ponikau |
Pharmaceutical composition for treating and preventing inflammation of mucosal tissue
|
|
WO2000023081A1
(en)
|
1998-10-20 |
2000-04-27 |
Lauteral Limited |
Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity
|
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
|
US20060264409A1
(en)
|
2004-01-20 |
2006-11-23 |
Harty Richard F |
Compositions and methods of treatment for inflammatory diseases
|
|
US20080194456A1
(en)
*
|
2004-04-09 |
2008-08-14 |
The General Hospital Corporation |
Compositions And Methods Related To An Intestinal Inflammation And Uses Therefor
|
|
CN101039701A
(zh)
*
|
2004-08-26 |
2007-09-19 |
尼古拉斯皮拉马尔印度有限公司 |
含有生物可裂解二硫化物连接物的前药和共药
|
|
WO2008002971A2
(en)
*
|
2006-06-29 |
2008-01-03 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
MXPA06014635A
(es)
|
2006-12-14 |
2008-11-26 |
Senosiain S A De C V Lab |
Composicion farmaceutica que contiene una combinacion de antibiotico y mucolitico y su uso.
|
|
US8821928B2
(en)
|
2007-06-04 |
2014-09-02 |
Egalet Ltd. |
Controlled release pharmaceutical compositions for prolonged effect
|
|
GB0823472D0
(en)
*
|
2008-12-23 |
2009-01-28 |
Photocure Asa |
Product
|
|
US9408393B2
(en)
|
2010-02-03 |
2016-08-09 |
Microbion Corporation |
Bismuth-thiols as antiseptics for agricultural, industrial and other uses
|
|
GB0905451D0
(en)
|
2009-03-31 |
2009-05-13 |
Novabiotics Ltd |
Biofilms
|
|
AU2011212941B2
(en)
*
|
2010-02-03 |
2016-03-03 |
Microbion Corporation |
Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
|
|
GB201021186D0
(en)
|
2010-12-14 |
2011-01-26 |
Novabiotics Ltd |
Composition
|
|
BR112015004165A2
(pt)
|
2012-08-29 |
2017-07-04 |
Salix Pharmaceuticals Inc |
métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas
|
|
WO2014036445A2
(en)
*
|
2012-08-31 |
2014-03-06 |
Johnson Michael R |
Novel mucolytic agents
|
|
CN104812369B
(zh)
|
2012-10-26 |
2017-11-24 |
心悦生医股份有限公司 |
壳核粒子与其制造方法以及含有壳核粒子的组合物
|
|
CA3153463A1
(en)
|
2012-10-29 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treating mucosal tissue disorders
|
|
EP2991649B1
(en)
|
2013-04-30 |
2020-06-03 |
Thomas Julius Borody |
Compositions for treating obsessive-compulsive disorder
|
|
ITMI20130874A1
(it)
*
|
2013-05-29 |
2014-11-30 |
Zambon Spa |
Compresse deglutibili di n-acetilcisteina
|
|
US20160158262A1
(en)
*
|
2013-07-26 |
2016-06-09 |
Cedars-Sinai Medical Center |
Methods of treating irritable bowel syndrome
|
|
MX381919B
(es)
|
2014-06-30 |
2025-03-13 |
Salix Pharmaceuticals Inc |
Métodos para repetir tratamiento de síndrome del intestino irritable (ibs).
|
|
US10953070B2
(en)
*
|
2014-07-25 |
2021-03-23 |
Agency For Science, Technology And Research |
Antibiotic compositions for treating bacterial infections
|
|
RU2737891C2
(ru)
*
|
2015-04-30 |
2020-12-04 |
Пробиотикал С.П.А |
Применение антибиотиков со специфичными терапевтическими активностями в комбинации с одновременным применением лактобацилл и/или бифидобактерий с непередающейся устойчивостью к антибиотикам, имеющих такое же терапевтическое показание
|
|
WO2017210428A1
(en)
|
2016-06-01 |
2017-12-07 |
Crestovo Llc |
Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders
|
|
GB201621447D0
(en)
|
2016-12-16 |
2017-02-01 |
Novabiotics Ltd |
Use
|
|
CA3055311A1
(en)
*
|
2017-02-07 |
2018-08-16 |
Stc.Unm |
Isotope enhanced ambroxol for long lasting autophagy induction
|
|
WO2018174839A1
(en)
|
2017-03-18 |
2018-09-27 |
Nguyen Mark Quang |
Cysteine, n-acetylcysteine and penicillamine prodrugs, pharmaceutical compositions thereof, and methods of use
|
|
JP2020513041A
(ja)
|
2017-04-10 |
2020-04-30 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ |
病原体の阻害および／または粘液の改変のための化合物、組成物、および方法
|
|
KR20200060424A
(ko)
|
2017-09-20 |
2020-05-29 |
아토픽 메디컬, 엘엘씨. |
호흡기 질환 및 점막 염증의 치료 및 개선을 위한 조성물 및 방법
|
|
US20220186281A1
(en)
|
2019-01-30 |
2022-06-16 |
Cedars-Sinai Medical Center |
Method for processing and analysis of viscous liquid biological samples
|
|
CA3132400C
(en)
|
2019-03-18 |
2026-05-12 |
Cedars-Sinai Medical Center |
Compositions and methods to treat gastrointestinal diseases and disorders
|
|
JP2025516807A
(ja)
|
2022-05-19 |
2025-05-30 |
シーダーズ－サイナイ メディカル センター |
リファキシミンとｎ－アセチルシステインの製剤
|